AI, breast cancer

AI helps radiologists spot breast cancer in real-world tests
Whether AI can assist in cancer detection has been subject to much debate, but now a real-world test with almost 200 radiologists shows that the technology can improve success rates
AI helps doctors detect more breast cancer in the largest real-world study
AI is as good as clinicians at interpreting mammograms, a cancer study with nearly 500,000 participants in Germany suggests.
AI increases chances to detect breast cancer, study finds
Researchers have indicated the use of AI in breast cancer screening increases the chances of detecting the disease. There have been claims that AI could assist clinicians in combating cancer cases, but much of this has been based on retrospective work.
AI-Supported Mammography Revolutionizes Breast Cancer Detection: Landmark German Study Proves Real-World Impact
PRAIM stands out as the most ambitious AI radiology project to date, involving 500,000 participants across Germany. As the first nationwide study to deploy AI in Germany's National Screening Program, it far surpasses previous studies that relied on retrospective data or small, controlled lab settings
AI powered blood test spots earliest breast cancer signs
Standard tests for breast cancer can include a physical examination, x-ray or ultrasound scans or analysis of a sample of breast tissue, known as a biopsy. Existing early detection strategies rely upon screening people based on their age or if they are in at-risk groups.
Study Demonstrates AI's Power in Improving Breast Cancer Detection
For years, the idea that "AI will replace radiologists" has been largely speculative. Today, a groundbreaking study provides the first real-world evidence of artificial intelligence's potential to transform breast cancer screening.
ScreenPoint Medical Acquires Biomediq A/S to Expand Breast Cancer Risk Assessment Capabilities
ScreenPoint Medical today announced the acquisition of Biomediq A/S, a research-based company focused on the research, ...
How AI saved 68-year-old Sheila Tooth when routine scan missed cancer
The advancement offers hope for better patient outcomes.The pilot study, published in the Journal of Biophotonics, involved ...
AFP22h
Aiosyn Mitosis Breast Becomes the First AI-Powered Mitosis Detection Solution to Achieve CE Mark Certification Under IVDR
Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has announced that its ...
Crain's New York1d
NYU Langone offshoot raises $20M in growing field of AI cancer diagnostics
The city’s abundance of large health systems has produced a cottage industry of AI-centered medical diagnostics companies ...
U.S. News & World Report13d
Could AI Plus Lasers Help Catch Very Early Breast Cancers?
Could AI Plus Lasers Help Catch Very Early Breast ... The small study involved 24 blood samples: 12 obtained from breast cancer patients and 12 from healthy people. The new technology involves ...
TMCnet8d
Artificial Intelligence (AI) in Cancer Market to Grow at a CAGR of 23.1%
BOSTON, Dec. 30, 2024 /PRNewswire/ -- According to the latest study from BCC Research, " Artificial Intelligence (AI) in Cancer " is estimated to increase from $2.2 billion in 2024 to reach $6.3 ...
AI is better at spotting certain cancer than doctors, scientists say
Researchers say the AI-powered tool is better at spotting ovarian cancer than expert ultrasound examiners and could reduce ...
Pharmaceutical Technology2d
Pocenbrodib hydrochloride by Pathos AI for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Likelihood of Approval
Pocenbrodib hydrochloride is under clinical development by Pathos AI and currently in Phase I for Metastatic Castration-Resistant Prostate Cancer (mCRPC).